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1. Introduction
   TB has been known as a causative agent of the global 
morbidity and mortality during the history[1,2]. TB is 
still an important public health problem that occurs in 
numerous countries regardless of their economic and 
social situation[3-5]. The emergence of multi-drug resistant 
tuberculosis (MDR-TB) is one of the most hazardous events 
that threaten the public health. Of 250 000 individuals 
with the multidrug resistant TB, only 12% were diagnosed 
in 2009[6], and also 8.7 million people infected with 
Mycobacterium tuberculosis (M. tuberculosis) and 1.4 million 
deaths in 2011[4]. The increase in emergence of MDR-TB 
leads to raise the mortality, treatment failure rates and the 
period of transmissibility of the infection[1]. Generally, the 
MDR-TB includes the strains resistant to at least isoniazid 
(INH) and rifampin (RIF), the more efficient first-line drugs 
against TB[1,3,7]. The occurrence of mutations within several 
known genes is responsible for the MDR-phenotype. 
Discrepant mutations of the katG, inhA, ahpC, kasA genes 
involved in INH resistance. This drug is administered as a 
pro-drug and products of the described genes are capable 
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to convert it to an active form. For instance, catalase-
proxidase (encoded by katG) produces free radicals and 
leading to activate INH. Furthermore, enoyl-acyl carrier 
protein reductase and keto acyl-acyl carrier protein 
synthase are other two important enzymes involved in the 
INH activation in the target cells that are encoded by the 
inhA and kasA genes, respectively. Mutations in these genes 
lead to perturb mycolic acid biosynthesis. Overall, 50%-90% 
of reported mutations in MDR-TB cases have occurred in the 
katG gene, especially Ser315Thr[8,9]. Moreover, 20%-30% of 
INH resistant cases have mutations in the promoter region of 
the inhA gene.
   The rpoB gene encodes the β-subunit of the RNA 
polymerase[9]. Several studies demonstrated that mutations 
in this gene cause resistance to RIF. Most prevalent 
mutations have been reported within the core region of the 
rpoB with the length of 81 bp. The type of these mutations 
are deletions, insertions and missense mutations that 
present in 95%-96% of the rifampin-resistant cases[10]. 
More than 35 mutations have been found in the core region, 
however, missense mutations at codon 516, 526 or 531 are 
most prevalent[11].
   To limit the spread of MDR-TB, it is necessary to design an 
efficient method for monitoring the level of drug resistance. 
Common conventional methods used in clinical laboratory 
can determine resistant isolates by the drug susceptibility 
testing in the phenotypic manner. These methods are time 
consuming because M. tuberculosis requires at least 6-8 
weeks to grow and yield visible colonies on culture medium 
containing antibiotics. Recently, the increase of our 
knowledge about the genetic mechanisms of the resistance 
allows establishing molecular methods for detection of drug 
resistant cases. However, most of them focused on single 
or/and single drug. Few studies performed by Mokrousov et 
al.[12], Marine et al.[13], and Yang et al.[14] designed methods 
that were able to assess the resistant to both INH and RIF, 
but most of them are expensive and demand more technical 
and equipment requirements.
   In the present study, we attempted to design a rapid and 
efficient molecular method based on polymerase chain 
reaction-single strand conformation polymorphism (PCR-
SSCP) that can detect all the mutations in the katG and rpoB 
genes which contribute in MDR-TB phenotype. In addition, 
we compared our findings to results from sequencing and 
conventional methods among clinical isolates.
2. Materials and methods
2.1. Sample collection
   In this study, clinical specimens from suspected patients 
were collected from the Baqiyatallah Hospital in north of 
Tehran, Iran during 2009-2011. To recognize specimens 
containing M. tuberculosis, sepecimens were processed[15] 
and were cultured on the Lowenstein-Jensen medium. The 
suspected mycobacterial colonies were checked for niacin 
production, nitrate reductase, resistance to thiophen-
2-carboxylic acid hydrazide and catalase tests. Isolates 
eventually were assayed by PCR targetting IS6110[16]. 
2.2. Drug-susceptibility testing
   The proportional method was used to assess the 
susceptibility of isolates to INH (0.2 µg/mL) and RIF (4 µg/
mL)[17]. The results were interpreted according to WHO 
guidelines[18].
2.3. DNA extraction
   Genomic DNA of M. tuberculosis isolates was extracted 
using phenol-chloroform method[1]. The concentration DNA 
was measured at 260 nm using Nanodrop (Thermo Scientific, 
USA). 
2.4. PCR condition
   Primers described by Cheng et al. were used to amplify 
the rpoB and katG genes as follow: forward 5′-CGG CGA 
TGA GCG TTA CAC-3′ and reverse 5′-CGT CCT TGG CGG TGT 
ATT-3′ for katG (Accession number X68081) with 458 bp 
PCR product, also forward 5′-CAG ACG TTG ATC AAC ATC 
CG-3′ and reverse 5′-TAC GGC GTT TCG ATG AAC-3′ for rpoB 
(Accession number L27989) with 305 bp PCR product[1]. 
The position of katG463 known as natural polymorphism, 
therefore this position is not including in amplifying 
region[19-21]. The PCR were optimized for the amplification 
of the rpoB and katG genes. The PCR reactions were done 
in a final volume of 25 µL containing 2.5 µL of 10伊 PCR 
buffer, 1 µL of 2.5 mmol/L of each deoxy-ribonucleoside 
triphosphate, 1 µL of 10 pmol/L of each desired reverse 
and forward primer, 1.5 and 3.5 µL of 50 mmol/L MgCl2 
respectively for rpoB and katG, 1 IU of Taq polymerase 
(CinnaClon Co., Iran), and 2-5 ng of DNA template. The 
thermocycler program of PCR reactions was performing with 
an initial denaturation step of 5 min at 95 °C; 40 cycles of 30 
seconds at 95 °C, 30 seconds at an appropriate temperature, 
and 45 seconds at 72 °C, and a final extension step of 7 min 
at 72 °C.
   The annealing temperatures for rpoB and katG were 
optimized at 61 °C and 60 °C, respectively. The amplicon 
of each reaction was tested by electrophoresis on 1.5% 
agarose gel and visualized under UV illumination after 
staining with ethidium bromide (0.5 mg/mL). For further 
confirmation, relative bands from all PCR products were 
amplified with the Pfu polymeraseand sequenced (Gene 
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Fanavaran Co. Iran). M1 and M2 strains were prepared from 
tuberculosis center of the Masih Daneshvari Hospital as 
MDR-TB strains and used as a mutant control. H37Rv, a 
susceptible strain, was used as a wild type control.
2.5. Single strand conformational polymorphism testing 
(SSCP)
   Amplified products from described PCR were mixed with 
anequal volume of formamide loading dye (97% formamide, 
0.05% bromphenol blue and 20 mmol/L ethylene diamine 
tetraacetic acid. After denaturing of these mixtures at 
95 °C for 6 min for rpoB and 75 °C for 2 min for katG, the 
products were loaded onto 8 cm伊7 cm gel containing 
10.5% acrylamide:bisacrylamid (29:1) and 10% glycerol and 
electrophoresis were carried out at 100 V for 4 h for rpoB 
amplicon and 8 h for the katG amplicon in TBE 0.5伊 at room 
temperature. Consequently, the gel was stained by the 
silver staining method as described by Bassam et al[22].
3. Results
3.1. Drug susceptibility testing 
   By using specific biochemical test and PCR assay, 103 
samples containing M. tuberculosis were isolated. Results 
obtained from drug susceptibility testing showed that 12 
(11.6%) isolates were resistant to at least one antibiotic, INH 
or RIF. Furthermore, 9 (8.7%) isolates out of 12 showed the 
resistance properties to both INH and RIF simultaneously 
that they are known as MDR-TB. Three isolates were only 
resistant to INH. Table 1 illustrates the pattern of drug 
resistance of isolates under study.
3.2. PCR-SSCP results
   To amplify the rpoB and katG genes, we designed 
PCR, respectively. PCR condition for rpoB and katG were 
optimized for detecting of clinical isolates. The amplified 
fragments for the rpoB and katG genes are 305 bp and 458 
bp, respectively. To determine the presence of known and 
unknown mutations within the mentioned genes, SSCP was 
applied. Figures 1 and 2 show examples of results from 
PCR-SSCP isolates. Overall, 6 (5.82%) isolates had a mutation 
at least in one gene compared to the H37Rv strain (Table 
1). Among these isolates, 3 (2.9%) isolates were categorized 
in the MDR-TB group because of having mutations 
simultaneously in the rpoB and katG. In addition, 
mutations within the rpoB (resistant to RIF), katG (resistant 
to INH) genes were observed in one and two isolates, 
respectively. All the MDR-TB and two of INH resistant 
isolates were also identified by drug susceptibility testing.
Table 1
The comparison of results obtained from three methods, the drug susceptibility 
testing, the sequencing and PCR-SSCP, performed in this study.
Code Phenotypic Sequencing
SSCP
rpoB katG
B5 Resistance to INH AGC→ACC ( Ser→Thr) Codon 315 katG R R
Resistance to RIF TCG→ TTG ( Ser→Leu) Codon 531 rpoB
Z21 Resistance to INH AGC→ACC ( Ser→Thr) Codon 315 katG S R
Susceptible to RIF NA
E31 Resistance to INH Negative S S
Resistance to RIF Negative
E4 Resistance to INH Negative S S
Susceptible to RIF NA
E13 Resistance to INH Negative S S
Resistance to RIF Negative
E19 Resistance to INH Negative S S
Resistance to RIF Negative
K11 Resistance to INH AGC→ACC ( Ser→Thr) Codon 315 katG R R
Resistance to RIF TCG→ TTG ( Ser→Leu) Codon 531 rpoB
Z33 Resistance to INH AGC→ACC ( Ser→Thr) Codon 315 katG S R
Susceptible to RIF NA
S1 Susceptible to INH NA R S
Susceptible to RIF NA
S3 Resistance to INH Negative S S
Resistance to RIF Negative
S5 Resistance to INH AGC→ACC ( Ser→Thr) Codon 315 katG R R
Resistance to RIF TCG→ TTG ( Ser→Leu) Codon 531 rpoB
E’4 Resistance to INH Negative S S
Resistance to RIF Negative
E17 Resistance to INH Negative S S
Resistance to RIF Negative
All of  isolates were detected resistance by at least one of the three methods. 
NA: not assay.
  1             2            3           4           5             6           7             8
rpoB (Band 1)
rpoB (Band 2)
rpoB (Band 3)
Figure 1. Gel electrophoresis of PCR-SSCP products of the rpoB gene. 
Lanes numbered 1, 4 show patterns of rpoB of H37Rv (without mutation), and 
rpoB of H37Rv (without mutation), respectively; lane 3 is a mixture of PCR 
without our considred amplicons as negative control for SSCP test; lane 2 is 
a pattern of the M1 strain as a MDR sample; lane 5 shows a mutation in each 
three band of rpoB; lanes 6, 7 and 8 are clinical samples without mutation.
  1             2            3           4           5             6           7             8
katG (Band 1)
katG (Band 2)
Figure 2. Gel electrophoresis of PCR-SSCP products of the katG gene. 
Lane 1 is a pattern of clinical sample without mutation; Lane 2 is M1 with 
mutation in band 2 of katG; Lanes numbered 3, 5, 6, 7 and 8 show the 
presence of mutation that have been represented in band 2; lane 4 is H37Rv 
(a negative control without mutation).
3.3. DNA sequencing
   To confirm the findings from SSCP, 12 (11.6%) resistant 
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isolates separated using the drug susceptibility test, DNA 
sequencing method was done. Three (2.9%) MDR-TB and two 
INH resistant isolates were detected by this method and also 
by both other methods. 
   All the mutations emerged within the rpoB and katG genes 
were Ser531Leu and Ser315Thr, respectively (Table 1).
3.4. Specificity and sensitivity
   To determine the specificity and sensitivity of our 
methods, the drug susceptibility testing was utilized as 
an standard method. Sensitivity defined as probability of 
mutation pattern if the resistances have been shown by 
phenotypic drug susceptibility testing[1]. Specificity defined 
as probability of wild pattern if the susceptibility has been 
shown by phenotypic drug susceptibility testing[1]. From 
nine MDR isolates, only three were recognized by the PCR-
SSCP, therefore the sensitivity of our method was 33.33%. Five 
of 12 INH resistant strains showed mutation by PCR-SSCP and 
the sensitivity was measured as 41.67%. Also three of nine 
RIF resistane strains detected by PCR-SSCP and sensitivity 
was measured as 33.33%. Since the results from sequencing 
test were similar to findings from PCR-SSCP, sensitivity 
of both tests were equal. The specificity of PCR-SSCP and 
sequencing for MDR, INH resistant and RIF resistant strains 
were 100%, 100% and 98.94%, respectively. Table 2 shows the 
sensitivity and specificity of discrepant resistant groups of 
isolates in details.
Table 2
The sensitivity and specificity of the PCR-SSCP and DNA sequencing for 
detection of drug resistance strains.
Drug and genre
Number of 
resistance 
isolates
Number Sensitivity
Specificity 
(%)SSCP Seq. SSCP (%) Seq. (%)
INH resistance 12 5 5 41.67 41.67
100.00
NMIR  3 2 2 66.66 66.66
MIR  9 3 3 33.33 33.33
INH Sus. 91   91 - - -
RIF resistance  9 3 3 33.33 33.33
98.94MRR  9 3 3 33.33 100
RIF Sus. 94   93 - - -
MDR  9 3 3 33.33 33.33
100.00
None MDR 94   94 - - -
NMIR: non MDR INH resistance; MIR, MRR: MDR INH resistance and MDR 
RIF resistance respectively; INH Sus, RIF Sus: susceptible to INH and RIF 
respectively; Seq.: DNA sequencing.
4. Discussion
   Controlling and decrease the rate of M. tuberculosis 
particularythe MDR-TB is a highlight subject that is aimed 
by public healthcare systems worldwide. The classical 
diagnostic method based on culture and phenotypic drug 
susceptibility testing are common methods for detecting 
clinical samples containing M. tuberculosis. Although 
these methods have been approved as a gold standard, 
they require at least 6-8 weeks representing outcomes. 
Developing arapid detection method is essential in this 
field. However, researchers designed several molecular 
methods for this concept, but most of them are expensive 
and need specific equipments that are unavailable in 
numerous countries. In the present study, we designed PCR-
SSCP method which is capable to detect mutations within two 
genes, the katG and rpoB genes, simultaneously during 13 h. 
In addition, this method can be done in laboratories with a 
limited equipment and space.
   To our knowledge, few studies attempted to detect RIF and 
INH resistant strains by using PCR-SSCP, simultaneously. At 
the first time, Cheng et al. developed the detection method 
based on PCR-SSCP[1]. In this study, known and unknown 
mutations created in the katG, inhA and rpoB genes which 
respectively involve in the RIF and INH resistance by using 
multiplex PCR-SSCP. Data from that showed that designed 
method is capable to screen more up to 80% of resistant 
clinical isolates. Its specificity for RIF and INH was 92% and 
100%, respectively[1]. In another study performed by Chan et 
al.[23], the resistance to ofloxacin, rifampicin, ethambutol, 
isoniazid and pyrazinamide, anti-mycobacterium drugs, 
was evaluated by SSCP/multiplex PCR amplimer conformation 
analysis. They identified 102 new mutations within the 
seven genes named the gyrA, rpoB, embB, katG, inhA, 
ahpC and pncA genes, which contribute in the resistance to 
five described drugs[23]. It should be noted that numerous 
resistant isolates showed no mutations in the interest genes 
in this study. The purified DNA obtained from culture of 
clinical samples was utilized in both studies mentioned 
above.
   Recently, Grutzmacher et al. evaluated of resistance to 
five antibiotics described above by detecting mutations 
within the gyrA, rpoB, embB, katG, inhA, ahpC and pncA 
genes by the PCR-SSCP in clinical sputum samples[24]. In 
this study, only one sample that was resistant to ethambotol, 
represented the mutation within the embB gene by SSCP and 
other resistant samples detected by phenotypic diagnostic 
methods had wild-type patterns. In this study, the authors 
reported that PCR-SSCP wasn’t able to screen resistant strains 
compared to classical methods.
  Here, our objective was to assess potency of PCR-SSCP 
as a rapid screening tool for determination of resistant 
M. tuberculosis strains. Despite of low sensitivity, all the 
mutations determined by sequencing method were identified 
by our PCR-SSCP method that it showed the accuracy of 
our methods. Higher frequency of resistant strains was 
recognized by the drug susceptibility testing. According 
to agreement between sequencing tests and SSCP test 
and significant difference between them and phenotypic 
drug susceptibility test, we can conclude that resistance-
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associated mutations occurred in other genes except katG 
and considered region of rpoB which weren’t analyzed by 
our method. Coll et al.[25], Piatek et al.[26] and Tudo et al.[27] 
have reported high rate of resistance-associated mutations 
in genes except katG which are match with our result 
and confirm our findings. Since genes involved in drug 
resistance is a region specific and discrepant geographical 
regions have a different gene pattern, it is necessary to 
identify this pattern for each country to increase capability 
of this method. Furthermore, usage of DNA purified from 
colonies but not directly from clinical samples is another 
finiteness of our developed method that requires justifying.
   Considred to high specificity of our test, we can utilize this 
method together with gold standard methods including drug 
susceptibility testing. In addition to speed and accuracy, 
our method was optimized in room temperature and for 8 cm
伊7 cm gel, therefore this is applicable in a broad range of 
laboratories even in poor economic region.
   According to agreement among sequencing, SSCP tests and 
significant difference with phenotypic drug susceptibility 
method, we conclude that resistance-associated mutations 
can occur in other genes except katG and considered region 
of rpoB.
   High rate of resistance-associated mutations in genes 
except katG have been reported which are match with our 
result and confirm our findings.
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Comments 
Background
   M. tuberculosis is an important pathogen and an important 
public health problem that occurs in numerous countries. 
Currently, the strains with MDR-TB are a complicate problem 
in these countries. Therefore it is necessary to design an 
efficient method for monitoring the level of drug resistance. 
In this study, authors attempted to design a rapid and 
efficient molecular method based on PCR-SSCP that can 
detect all the mutations in the katG and rpoB genes which 
contribute in MDR-TB phenotype. In addition, the authors 
compared their findings to results from sequencing and 
conventional methods among clinical isolates.
Research frontiers
   M. tuberculosis is an important pathogen and an important 
public health problem that occurs in numerous countries 
especially Iran. Currently, the strains with MDR-TB are a 
complicate problem in Iran. Therefore it is necessary to 
design an efficient and fast method for monitoring the level 
of drug resistance.
Related reports
   Cheng et al. studied a new Multi-PCR-SSCP assay for 
simultaneous detection of INH and RIF resistance in M. 
tuberculosis. Study of efficient method for monitoring the 
level of drug resistance in M. tuberculosis is very few in 
Tehran, Iran. 
Innovations and breakthroughs
   In this study, the authors attempted to design a rapid and 
efficient molecular method based on PCR-SSCP that can 
detect all the mutations in the katG and rpoB genes which 
contribute in MDR-TB phenotype. In addition, the authors 
compared their findings to results from sequencing and 
conventional methods among clinical isolates in Iran.
  
Applications
   Controlling and decreasing the rate of M. tuberculosis 
particularly the MDR-TB is a highlight subject that is aimed 
by public healthcare systems worldwide especially Iran. In 
this study, they designed PCR-SSCP method which is capable 
to detect mutations within two genes, the katG and rpoB 
genes, simultaneously during 13 h. In addition, this method 
can be done in laboratories with a limited equipment and 
space.
Peer review
   This is a good study in which the authors evaluated PCR-
SSCP method which is capable to detect mutations within two 
genes, the katG and rpoB genes, simultaneously during 13 
h. The results are interesting and suggest that this method 
is a appropriate technique for rapid detection of MDR-M. 
tuberculosis from clinical specimens. 
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